Immunogenicity
We will assess the immunogenicity of your advanced therapies throughout the preclinical and clinical stages.
Evaluating Immunogenicity in Genetic Medicine
Characterizing immunogenicity is critical to developing safe and effective advanced therapies, including genetic medicines. Antibodies against adeno‑associated viruses (AAVs), whether from natural infection or vector administration, can impact therapeutic efficacy. Neutralizing antibodies, in particular, can diminish the effectiveness of AAV-based treatments. Immune responses can range from no clinical effect to severe, life-threatening reactions involving innate and adaptive immunity.
Immunogenicity Services
Anti-AAV Capsid Humoral ResponseWe offer AAV Neutralizing Antibody (NAb) and Binding Antibody (BAb) assays across a range of AAV serotypes, species, and biological matrices.
IFN-γ ELISpot AssayT cell response evaluations are available for multiple species. Services include procurement and qualification of peptide libraries.
Lymphocyte IsolationWe provide lymphocyte isolation services from whole blood, liver, spleen, bone marrow, and lymph node.
Anti-AAV Capsid Humoral ResponseWe offer AAV Neutralizing Antibody (NAb) and Binding Antibody (BAb) assays across a range of AAV serotypes, species, and biological matrices.
IFN-γ ELISpot AssayT cell response evaluations are available for multiple species. Services include procurement and qualification of peptide libraries.
Lymphocyte IsolationWe provide lymphocyte isolation services from whole blood, liver, spleen, bone marrow, and lymph node.
Assay Development and ValidationCustom assay development is available for NAb, BAb, and ELISpot assays, including support for novel serotypes, various species, and regulated (GLP) studies.
GLP-Compliant ServicesGood Laboratory Practice (GLP)-compliant assays are available for early-phase clinical programs. We offer program-specific assay and reagent validation under GLP, with expert consultation.
Assay Development and ValidationCustom assay development is available for NAb, BAb, and ELISpot assays, including support for novel serotypes, various species, and regulated (GLP) studies.
GLP-Compliant ServicesGood Laboratory Practice (GLP)-compliant assays are available for early-phase clinical programs. We offer program-specific assay and reagent validation under GLP, with expert consultation.
Featured News & Events
Advance Your Research with Our Immunogenicity Experts
Our experts are here to support your preclinical and clinical programs with extensive immune response evaluation.
Contact Us